Alkermes has a huge opportunity to expand its label to include pediatric patients with Schizophrenia and bipolar I disorder.

The schizophrenia market size is expected to grow during the forecast period (2025–2034). DelveInsight’s analysis projects growth in the schizophrenia market, driven by rising disease prevalence, the ...

Are substance-induced psychosis and primary psychosis fundamentally different? And if they are, does it matter?

Opioids, antidepressants, and some NSAIDs increase the risk of constipation. Find out which ones do and what helps bowel ...

For some patients, simulated situations controlled by therapists may be less overwhelming than real-life exposure therapy.

Attorneys from Wisner Baum filed the complaint on behalf of plaintiff Bridgett Brown, who was prescribed both brand-name and generic versions of Risperdal and Zyprexa. She was diagnosed with ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, ...

Across the U.S., some people with mental illness wait months in jail for court-ordered competency evaluations, with little to ...